日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators

获得的靶向改变导致对 p53-Y220C 激活剂的临床耐药性

Fece de la Cruz, Ferran; Varkaris, Andreas; Patel, Parasvi S; Kushner, Elijah W; Morales-Giron, Alvin A; Lee, Sangmi Sandra; Singh, Ankit; Kim, Clara T; Norden, Bryanna L; Ehnstrom, Sara; Riedl, Jakob M; Curtis, Jacquelyn M; Barnes, Haley; Kehlmann, Allison M; Chevalier, Nicholas J; Okuma, Hitomi S; Patel, Manisha; Wirth, Lori J; Connell, Brendan; Nugent, Francis; Pappas, Leontios; Lau, Kayao; Juric, Dejan; Hopkins, Jessica L; Guiley, Keelan Z; Shokat, Kevan M; Gulhan, Doga C; Parikh, Aparna R; Corcoran, Ryan B

MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response

MAPK通路突变出现在对IDH1抑制剂耐药的胆管癌中,并减弱IFN反应

Wan, Jinkai; Saatcioglu, Hatice Duygu; Ellis, Haley; Aguado-Fraile, Elia; Xu, Qin; Kondo, Hiroshi; Manguso, Robert T; Gritti, Ilaria; Norden, Bryanna L; Noble, Carolina; Corcoran, Ryan B; Lubner, Sam J; Javle, Milind; Abou-Alfa, Ghassan K; Cleary, James M; Kelley, Robin K; Borad, Mitesh J; Macarulla, Teresa; Oh, Do Youn; Daigle, Scott; Gliser, Camelia; Pandya, Susan; Choe, Sung; Tron, Adriana E; Bardeesy, Nabeel

Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors

肝转移对接受免疫检查点抑制剂治疗的微卫星稳定型转移性结直肠癌患者生存的影响

Pakvisal, Nussara; Pappas, Leontios; Caughey, Bennett A; Horick, Nora K; Tarazona, Noelia; Vora, Kruti B; Ouyang, Ben; Pandey, Aditya; Peacker, Bryan L; Sun, Joie; Zubiri, Leyre; Reynolds, Kerry L; Ryan, David P; Qadan, Motaz; Corcoran, Ryan B; Giantonio, Bruce; Allen, Jill N; Walsh, Elizabeth P; Clark, Jefferey W; Ting, David T; Parikh, Aparna R

Quantitative imaging of schwannoma captures heterogeneity and accelerates preclinical testing, revealing distinct impacts of targeted therapies.

神经鞘瘤的定量成像能够捕捉其异质性,加速临床前试验,揭示靶向治疗的不同效果。

Wright Emily A, Vitte Jeremie, Veiga Sara I, Bushnell Sarah E, Movsessian Catherine E, Zhang Youwen, Curtis Jacquelyn, Corcoran Ryan B, Stott Shannon L, Giovannini Marco, Chiasson-MacKenzie Christine, McClatchey Andrea I

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAF(V600E) metastatic colorectal cancer

恩科拉非尼、西妥昔单抗和纳武利尤单抗治疗微卫星稳定型BRAF(V600E)转移性结直肠癌的I/II期临床试验

Morris, Van K; Parseghian, Christine M; Bahrambeigi, Vahid; Abdelfattah, Nourhan; Xiao, Lianchun; Agrawal, Anjali; Lin, Kangyu; Raghav, Kanwal P S; Wolff, Robert A; Dasari, Arvind; Huey, Ryan W; Kee, Bryan K; Overman, Michael J; Willis, Jason A; Le, Phat H; Escano, Michelle; Baig, Yunyu C; Pan, Kelsey; Menter, David; Tam, Alda L; Foo, Wai C; Shen, Li; Lee, Hey Min; Gallup, Thomas D; Margain, Cori; Gallup, Dave; Rajapakshe, Kimal I; Guerrero, Paola A; Wang, Jing; Corcoran, Ryan B; Maitra, Anirban; Yun, Kyuson; Kopetz, Scott

TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

转移性乳腺癌患者中TOP1突变和抗体药物偶联物的交叉耐药性

Abelman Rachel O, Wu Bogang, Barnes Haley, Medford Arielle, Norden Bryanna, Putur Annika, Bitman Elena, Thant Win, Liu Ting, Weipert Caroline, Fell Geoffrey, Spring Laura M, Wander Seth A, Moy Beverly, Vidula Neelima, Isakoff Steven J, Varkaris Andreas, Juric Dejan, Corcoran Ryan B, Ellisen Leif W, Bardia Aditya

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

纳维托克和曲美替尼联合抑制BCL-xL和MEK治疗KRAS或NRAS突变晚期实体瘤的I/II期研究

Corcoran, Ryan B; Do, Khanh T; Kim, Jeong E; Cleary, James M; Parikh, Aparna R; Yeku, Oladapo O; Xiong, Niya; Weekes, Colin D; Veneris, Jennifer; Ahronian, Leanne G; Mauri, Gianluca; Tian, Jun; Norden, Bryanna L; Michel, Alexa G; Van Seventer, Emily E; Siravegna, Giulia; Camphausen, Kyle; Chi, Gary; Fetter, Isobel J; Brugge, Joan S; Chen, Helen; Takebe, Naoko; Penson, Richard T; Juric, Dejan; Flaherty, Keith T; Sullivan, Ryan J; Clark, Jeffrey W; Heist, Rebecca S; Matulonis, Ursula A; Liu, Joyce F; Shapiro, Geoffrey I

Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

利用仅检测血浆中循环肿瘤DNA的检测方法来预测根治性治疗后转移性结直肠癌的复发,从而评估微小残留病灶。

Parikh, Aparna R; Chee, Bryant H; Tsai, Jill; Rich, Thereasa A; Price, Kristin S; Patel, Sonia A; Zhang, Li; Ibrahim, Faaiz; Esquivel, Mikaela; Van Seventer, Emily E; Jarnagin, Joy X; Raymond, Victoria M; Corvera, Carlos U; Hirose, Kenzo; Nakakura, Eric K; Corcoran, Ryan B; Van Loon, Katherine; Atreya, Chloe E

Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer

晚期胃肠道癌症的患者报告结局、肿瘤标志物和生存结局

Jarnagin, Joy X; Saraf, Anurag; Baiev, Islam; Chi, Gary; van Seventer, Emily E; Mojtahed, Amirkasra; Allen, Jill N; Clark, Jeffrey W; Blaszkowsky, Lawrence; Giantonio, Bruce J; Weekes, Colin D; Klempner, Samuel J; Franses, Joseph W; Roeland, Eric J; Goyal, Lipika; Siravegna, Giulia; Horick, Nora; Corcoran, Ryan B; Nipp, Ryan D; Parikh, Aparna R

Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer

无细胞HPV DNA可对HPV相关头颈癌进行准确快速的诊断。

Siravegna, Giulia; O'Boyle, Connor J; Varmeh, Shohreh; Queenan, Natalia; Michel, Alexa; Stein, Jarrod; Thierauf, Julia; Sadow, Peter M; Faquin, William C; Perry, Simon K; Bard, Adam Z; Wang, Wei; Deschler, Daniel G; Emerick, Kevin S; Varvares, Mark A; Park, Jong C; Clark, John R; Chan, Annie W; Andreu Arasa, Vanessa Carlota; Sakai, Osamu; Lennerz, Jochen; Corcoran, Ryan B; Wirth, Lori J; Lin, Derrick T; Iafrate, A John; Richmon, Jeremy D; Faden, Daniel L